Sign in

CIK 0001619856 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Caribou Biosciences, Inc.

Sign in to watch
Ticker
CRBU
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
453728228
Phone
510-982-6030
Business address
2929 7TH STREET, SUITE 105, BERKELEY, CA, 94710
  1. 4 Open-market sale Chief Technology Officer sold 6,228 shares at $1.93 ($12,020)
  2. 4 Open-market sale Chief Technology Officer sold 3,147 shares at $1.96 ($6,168)
  3. 4 Open-market sale Chief Legal Officer sold 6,938 shares at $1.96 ($13,598)
  4. 4 Open-market sale Chief Business Officer sold 6,938 shares at $1.96 ($13,598)
  5. 4 Planned sale Chief Medical Officer sold 1,066 shares at $1.96 ($2,089)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Grant or award Chief Financial Officer acquired 55,000 shares (grant or award)
  14. 4 Grant or award President and CEO acquired 151,700 shares (grant or award)
  15. 4 Open-market buy President and CEO bought 20,000 shares at $1.02 ($20,400)
  16. 4 Grant or award President and CEO acquired 136,750 shares (grant or award)
  17. 4 Grant or award Chief Medical Officer acquired 14,589 shares (grant or award)
  18. 4 Open-market sale Chief Legal Officer sold 3,564 shares at $1.35 ($4,811)
  19. 4 Open-market sale Chief Business Officer sold 3,564 shares at $1.35 ($4,811)
  20. 4 Grant or award Chief Technology Officer acquired 37,500 shares (grant or award)

Page 1 of 7 · 125 filings